Aurobindo Pharma (NSE:AUROPHARMA) 3-Year Book Growth Rate : 16.80% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Aurobindo Pharma 3-Year Book Growth Rate?

Aurobindo Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Aurobindo Pharma's average Book Value per Share Growth Rate was 10.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was 16.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was 19.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Aurobindo Pharma was 37.60% per year. The lowest was 3.30% per year. And the median was 21.50% per year.

Competitive Comparison of Aurobindo Pharma's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurobindo Pharma's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Aurobindo Pharma's 3-Year Book Growth Rate falls into.

Aurobindo Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Aurobindo Pharma (NSE:AUROPHARMA) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Aurobindo Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma (NSE:AUROPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (NSE:AUROPHARMA) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

524804:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (NSE:AUROPHARMA) Headlines

No Headlines